Table 1. Baseline evaluation of the three groups.
| ADT group (n=46) | Non-ADT group (n=37) | Control group (n=50) | P value* | |
|---|---|---|---|---|
| Age (years) | 70.9±5.4 | 69.5±3.9 | 71.7±4.9 | 0.114 |
| Testosterone (ng dl−1) | 449±152 | 409±145 | 425±133 | 0.518 |
| Waist circumference (cm) | 86.6±6.4 | 85.6±6.6 | 86.1±5.8 | 0.762 |
| Fasting insulin (mU l−1) | 15.21±4.67 | 16.25±4.02 | 14.45±3.43 | 0.127 |
| Fasting glucose (mmol l−1) | 5.23±0.55 | 5.35±0.52 | 5.20±0.45 | 0.375 |
| Total cholesterol (mmol l−1) | 4.82±0.49 | 4.80±0.53 | 4.65±0.44 | 0.204 |
| Triglyceride (mmol l−1) | 1.55±0.42 | 1.47±0.36 | 1.40±0.29 | 0.138 |
| HDL (mmol l−1) | 1.32±0.23 | 1.28±0.28 | 1.25±0.19 | 0.366 |
| LDL (mmol l−1) | 3.03±0.56 | 2.87±0.56 | 3.08±0.43 | 0.165 |
Abbreviations: ADT, androgen deprivation therapy; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
*
One-way analysis of variance was used to compare parameters at baseline among the three groups.